• FirefoxTry Yahoo Finance on Firefox »
  •  Dow up 0.58% Nasdaq up 0.26%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow up 0.58% Nasdaq up 0.26%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
    Aug 29 30.25 -0.58 -1.88% 29.98 31.20 19,088,304 30,027,200 10.51B Sparkline Chart Chart, News, Stats, Options, Board
    Aug 29 39.39 -0.75 -1.87% 39.03 40.68 1,042,349 1,264,270 13.51B Sparkline Chart Chart, News, Stats, Board
    {"s" : "vrx,vrx.to","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Monday August 29, 2016
    Valeant is sued over Philidor ties, alleged racketeering Reuters05:41pm EDT
    Healthcare Winners: Stryker Corp., UnitedHealth Group Inc. Gurufocus05:03pm EDT
    Valeant is being sued under racketeering law over drug price hikes at MarketWatch04:35pm EDT
    Valeant (VRX) Stock Falls on Lawsuit at TheStreet03:58pm EDT
    Valeant Being Sued In NY Federal Court Over Alleged Overcharges Benzinga03:53pm EDT
    Bill Ackman Comments on Valeant Gurufocus01:07pm EDT
    EYEG: Posisitve Cataract Surgery Data, Initial CMHA-S Clinical Program Zacks Small Cap Research11:30am EDT
    [$$] Mylan to launch cut-price generic version of EpiPen at Financial Times10:00am EDT
    Sunday August 28, 2016
    Time to Shift Your Focus Yahoo Finance Contributors07:07am EDT
    Saturday August 27, 2016
    [$$] Hong Kong Tribunal Rules Against U.S. Short-Seller Andrew Left at The Wall Street Journal12:30am EDT
    Friday August 26, 2016
    MOVES-Pershing Square's Valeant analyst to exit, Ackman sees stock rising Reuters07:22pm EDT
    Bill Ackman Discusses Worst Year Ever in Mid-Year Letter Gurufocus07:02pm EDT
    MOVES-Pershing Square's Valeant analyst to exit, Ackman optimistic price Reuters05:48pm EDT
    Bill Ackman: Valeant 'One Very Big Mistake' Gurufocus04:24pm EDT
    One of the key men behind Bill Ackman's bet on Valeant is leaving to launch a healthcare startup Business Insider04:13pm EDT
    [$$] Hong Kong watchdog finds short seller culpable of market misconduct at Financial Times10:04am EDT
    Mylan offers price plan to help patients but its programs are still short on details at MarketWatch08:00am EDT
    Short seller Andrew Left deemed ‘reckless’ by Hong Kong regulator at MarketWatch07:53am EDT
    Thursday August 25, 2016
    [$$] Mylan: pen is not mightier at Financial Times01:29pm EDT
    Here's A Reason Why Valeant (VRX) Stock Is Climbing Today at TheStreet11:13am EDT
    The maker of the EpiPen is playing another dirty trick right from Martin Shkreli's book Business Insider11:10am EDT
    Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny at TheStreet10:39am EDT
    Valeant's Management Continues To Take The Right Steps Benzinga09:21am EDT
    Mylan says it will expand programs that lower EpiPen costs AP07:28am EDT
    Tuesday August 23, 2016
    Valeant Pays up for New CFO Herendeen at The Wall Street Journal06:13pm EDT